Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

4(80.0%)

N/A

1(20.0%)

5Total

Phase 2(4)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05411484Phase 2Active Not Recruiting

Investigation of Laser Assisted Drug Delivery of NanoDOX®

Role: collaborator

NCT01260675Completed

Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone

Role: lead

NCT00880841Completed

A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone

Role: lead

NCT02161354Phase 2Terminated

Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars

Role: lead

NCT01518491Phase 2Withdrawn

Open Label Trial of NanoDOX Hydrogel in Orthopedic Trauma Wounds With and Without Vacuum Assisted Closure Therapy

Role: lead

NCT00764361Phase 2Completed

Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers

Role: lead

NCT01547325Not ApplicableWithdrawn

Study of NanoDOX Hydrogel vs Placebo for Dehisced Surgical Wounds

Role: lead

All 7 trials loaded